Literature DB >> 26622558

JNK signaling pathway is involved in piperlongumine-mediated apoptosis in human colorectal cancer HCT116 cells.

Wen Li1, Chuangyu Wen2, Haiyan Bai3, Xiaoyan Wang2, Xiaoli Zhang4, Lanlan Huang2, Xiangling Yang2, Aikichi Iwamoto5, Huanliang Liu2.   

Abstract

Piperlongumine (PPLGM), an alkaloid isolated from the long pepper (Piper longum L.), can selectively trigger cancer cell death in colorectal cancer cells. The present study investigated whether the c-Jun NH2-terminal kinase (JNK) signaling pathway is involved in PPLGM-induced apoptosis in the human colorectal cancer HCT116 cell line. The results demonstrated that PPLGM reduced the cell viability and induced cell apoptosis in a time- and concentration-dependent manner, without a significant effect on cell cycle distribution. Meanwhile, treatment with 10 µM PPLGM resulted in JNK activation within 1 h, and a marked and sustained increase in c-Jun phosphorylation in the HCT116 cells. In addition, SP600125, a general inhibitor of JNK, inhibited PPLGM-induced apoptosis in the HCT116 cells by inhibiting PPLGM-induced c-Jun phosphorylation. Altogether, it can be concluded that the JNK signaling pathway, at least in part, is involved in PPLGM-mediated apoptosis in HCT116 cells.

Entities:  

Keywords:  SP600125; apoptosis; c-Jun NH2-terminal kinases; colorectal cancer; phosphorylation; piperlongumine

Year:  2015        PMID: 26622558      PMCID: PMC4509051          DOI: 10.3892/ol.2015.3371

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Induction of apoptosis by the transcription factor c-Jun.

Authors:  E Bossy-Wetzel; L Bakiri; M Yaniv
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

Review 2.  Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update.

Authors:  John M Kyriakis; Joseph Avruch
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases.

Authors:  A M Musti; M Treier; D Bohmann
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

Review 4.  Overview of the therapeutic potential of piplartine (piperlongumine).

Authors:  Daniel P Bezerra; Claudia Pessoa; Manoel O de Moraes; Nicolau Saker-Neto; Edilberto R Silveira; Leticia V Costa-Lotufo
Journal:  Eur J Pharm Sci       Date:  2012-12-11       Impact factor: 4.384

5.  Alkaloids of Piper longum Linn. I. Structure and synthesis of piperlongumine and piperlonguminine.

Authors:  A Chatterjee; C P Dutta
Journal:  Tetrahedron       Date:  1967-04       Impact factor: 2.457

6.  Activation of ERK signaling and induction of colon cancer cell death by piperlongumine.

Authors:  H Randhawa; K Kibble; H Zeng; M P Moyer; K M Reindl
Journal:  Toxicol In Vitro       Date:  2013-04-18       Impact factor: 3.500

7.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

8.  Up-regulation of c-Jun inhibits proliferation and induces apoptosis via caspase-triggered c-Abl cleavage in human multiple myeloma.

Authors:  Klaus Podar; Marc S Raab; Giovanni Tonon; Martin Sattler; Daniela Barilà; Jing Zhang; Yu-Tzu Tai; Hiroshi Yasui; Noopur Raje; Ronald A DePinho; Teru Hideshima; Dharminder Chauhan; Kenneth C Anderson
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

9.  Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited.

Authors:  Sarah A Molton; Daniel E Todd; Simon J Cook
Journal:  Oncogene       Date:  2003-07-24       Impact factor: 9.867

10.  Piperlongumine induces autophagy by targeting p38 signaling.

Authors:  Y Wang; J-W Wang; X Xiao; Y Shan; B Xue; G Jiang; Q He; J Chen; H-G Xu; R-X Zhao; K D Werle; R Cui; J Liang; Y-L Li; Z-X Xu
Journal:  Cell Death Dis       Date:  2013-10-03       Impact factor: 8.469

View more
  11 in total

1.  JNK inhibition blocks piperlongumine-induced cell death and transcriptional activation of heme oxygenase-1 in pancreatic cancer cells.

Authors:  Jiyan Mohammad; Rahul R Singh; Cody Riggle; Brandon Haugrud; Maher Y Abdalla; Katie M Reindl
Journal:  Apoptosis       Date:  2019-10       Impact factor: 4.677

2.  Transcriptome Analysis of Piperlongumine-Treated Human Pancreatic Cancer Cells Reveals Involvement of Oxidative Stress and Endoplasmic Reticulum Stress Pathways.

Authors:  Harsharan Dhillon; Sujan Mamidi; Phillip McClean; Katie M Reindl
Journal:  J Med Food       Date:  2016-04-27       Impact factor: 2.786

3.  Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Pathway.

Authors:  Yuan Yang; Jing-Yi Zhou; Li-Jun Zhao; Bao-Rong Gao; Xiao-Ping Wan; Jian-Liu Wang
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

4.  The role of MAPK signaling pathway in the Her-2-positive meningiomas.

Authors:  Zhaoyin Wang; Weijia Wang; Shan Xu; Shanshan Wang; Yi Tu; Yifeng Xiong; Jinhong Mei; Chunliang Wang
Journal:  Oncol Rep       Date:  2016-06-02       Impact factor: 3.906

5.  Discovery of piperlongumine as a potential novel lead for the development of senolytic agents.

Authors:  Yingying Wang; Jianhui Chang; Xingui Liu; Xuan Zhang; Suping Zhang; Xin Zhang; Daohong Zhou; Guangrong Zheng
Journal:  Aging (Albany NY)       Date:  2016-11-19       Impact factor: 5.682

6.  Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells.

Authors:  Cinara O D'Sousa Costa; João H Araujo Neto; Ingrid R S Baliza; Rosane B Dias; Ludmila de F Valverde; Manuela T A Vidal; Caroline B S Sales; Clarissa A G Rocha; Diogo R M Moreira; Milena B P Soares; Alzir A Batista; Daniel P Bezerra
Journal:  Oncotarget       Date:  2017-11-01

7.  Effects of Hylomecon vernalis ethanol extracts on cell cycle and apoptosis of colon cancer cells.

Authors:  Jing Sun; Xin Zhang; Yang Sun; Zhi-Shu Tang; Dong-Yan Guo
Journal:  Mol Med Rep       Date:  2017-04-03       Impact factor: 2.952

Review 8.  Caffeine and its main targets of colorectal cancer.

Authors:  Wen-Qi Cui; Shi-Tong Wang; Dan Pan; Bing Chang; Li-Xuan Sang
Journal:  World J Gastrointest Oncol       Date:  2020-02-15

Review 9.  Natural Health Products (NHP's) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends.

Authors:  Benjamin Scaria; Siddhartha Sood; Christopher Raad; Jana Khanafer; Rahul Jayachandiran; Alaina Pupulin; Sahibjot Grewal; Michael Okoko; Mansi Arora; Lauren Miles; Siyaram Pandey
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

10.  Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer.

Authors:  Jia-Rong Huang; Sheng-Te Wang; Meng-Ning Wei; Kun Liu; Jing-Wen Fu; Zi-Hao Xing; Zhi Shi
Journal:  Front Pharmacol       Date:  2020-11-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.